Bill Text: IL HB0488 | 2009-2010 | 96th General Assembly | Enrolled
Bill Title: Amends the Illinois Controlled Substances Act. Provides that any written prescription for a Schedule II controlled substance may be filled within 90 (rather than 7) days after issuance.
Spectrum: Partisan Bill (Democrat 2-0)
Status: (Passed) 2009-08-10 - Public Act . . . . . . . . . 96-0166 [HB0488 Detail]
Download: Illinois-2009-HB0488-Enrolled.html
|
|||||||
| |||||||
| |||||||
1 | AN ACT concerning criminal law.
| ||||||
2 | Be it enacted by the People of the State of Illinois,
| ||||||
3 | represented in the General Assembly:
| ||||||
4 | Section 5. The Illinois Controlled Substances Act is | ||||||
5 | amended by changing Section 312 as follows:
| ||||||
6 | (720 ILCS 570/312) (from Ch. 56 1/2, par. 1312)
| ||||||
7 | Sec. 312. Requirements for dispensing controlled | ||||||
8 | substances.
| ||||||
9 | (a) A practitioner, in good faith, may dispense a Schedule
| ||||||
10 | II controlled substance, which is a narcotic drug listed in | ||||||
11 | Section 206
of this Act; or which contains any quantity of | ||||||
12 | amphetamine or
methamphetamine, their salts, optical isomers | ||||||
13 | or salts of optical
isomers; phenmetrazine and its salts; or | ||||||
14 | pentazocine; and Schedule III, IV, or V controlled substances
| ||||||
15 | to any person upon
a written prescription of any prescriber, | ||||||
16 | dated and signed
by the
person prescribing on the day when | ||||||
17 | issued and bearing the name and
address of the patient for | ||||||
18 | whom, or the owner of the animal for which
the controlled | ||||||
19 | substance is dispensed, and the full name, address and
registry | ||||||
20 | number under the laws of the United States relating to
| ||||||
21 | controlled substances of the prescriber, if he is
required by
| ||||||
22 | those laws to be registered. If the prescription is for an | ||||||
23 | animal it
shall state the species of animal for which it is |
| |||||||
| |||||||
1 | ordered. The
practitioner filling the prescription shall write | ||||||
2 | the date of filling
and his own signature on the face of the | ||||||
3 | written prescription.
The written prescription shall be
| ||||||
4 | retained on file by the practitioner who filled it or pharmacy | ||||||
5 | in which
the prescription was filled for a period of 2 years, | ||||||
6 | so as to be readily
accessible for inspection or removal by any | ||||||
7 | officer or employee engaged
in the enforcement of this Act. | ||||||
8 | Whenever the practitioner's or
pharmacy's copy of any | ||||||
9 | prescription is removed by an officer or
employee engaged in | ||||||
10 | the enforcement of this Act, for the purpose of
investigation | ||||||
11 | or as evidence, such officer or employee shall give to the
| ||||||
12 | practitioner or pharmacy a receipt in lieu thereof. A | ||||||
13 | prescription
for a Schedule II controlled substance shall not | ||||||
14 | be filled more than 90 7 days
after the date of issuance. A | ||||||
15 | written prescription for Schedule III, IV or
V controlled | ||||||
16 | substances shall not be filled or refilled more than 6 months
| ||||||
17 | after the date thereof or refilled more than 5 times unless | ||||||
18 | renewed, in
writing, by the prescriber.
| ||||||
19 | (b) In lieu of a written prescription required by this | ||||||
20 | Section, a
pharmacist, in good faith, may dispense Schedule | ||||||
21 | III, IV, or V
substances to any person either upon receiving a | ||||||
22 | facsimile of a written,
signed prescription transmitted by the | ||||||
23 | prescriber or the prescriber's agent
or upon a lawful oral | ||||||
24 | prescription of a
prescriber which oral prescription shall be | ||||||
25 | reduced
promptly to
writing by the pharmacist and such written | ||||||
26 | memorandum thereof shall be
dated on the day when such oral |
| |||||||
| |||||||
1 | prescription is received by the
pharmacist and shall bear the | ||||||
2 | full name and address of the ultimate user
for whom, or of the | ||||||
3 | owner of the animal for which the controlled
substance is | ||||||
4 | dispensed, and the full name, address, and registry number
| ||||||
5 | under the law of the United States relating to controlled | ||||||
6 | substances of
the prescriber prescribing if he is required by | ||||||
7 | those laws
to be so
registered, and the pharmacist filling such | ||||||
8 | oral prescription shall
write the date of filling and his own | ||||||
9 | signature on the face of such
written memorandum thereof. The | ||||||
10 | facsimile copy of the prescription or
written memorandum of the | ||||||
11 | oral
prescription shall be retained on file by the proprietor | ||||||
12 | of the pharmacy
in which it is filled for a period of not less | ||||||
13 | than two years, so as to
be readily accessible for inspection | ||||||
14 | by any officer or employee engaged
in the enforcement of this | ||||||
15 | Act in the same manner as a written
prescription. The facsimile | ||||||
16 | copy of the prescription or oral prescription
and the written | ||||||
17 | memorandum thereof
shall not be filled or refilled more than 6 | ||||||
18 | months after the date
thereof or be refilled more than 5 times, | ||||||
19 | unless renewed, in writing, by
the prescriber.
| ||||||
20 | (c) Except for any non-prescription targeted | ||||||
21 | methamphetamine precursor regulated by the Methamphetamine | ||||||
22 | Precursor Control Act, a
controlled substance included in | ||||||
23 | Schedule V shall not be
distributed or dispensed other than for | ||||||
24 | a medical purpose and not for
the purpose of evading this Act, | ||||||
25 | and then:
| ||||||
26 | (1) only personally by a person registered to dispense |
| |||||||
| |||||||
1 | a Schedule V
controlled substance and then only to his | ||||||
2 | patients, or
| ||||||
3 | (2) only personally by a pharmacist, and then only to a | ||||||
4 | person over
21 years of age who has identified himself to | ||||||
5 | the pharmacist by means of
2 positive documents of | ||||||
6 | identification.
| ||||||
7 | (3) the dispenser shall record the name and address of | ||||||
8 | the
purchaser, the name and quantity of the product, the | ||||||
9 | date and time of
the sale, and the dispenser's signature.
| ||||||
10 | (4) no person shall purchase or be dispensed more than | ||||||
11 | 120
milliliters or more than 120 grams of any Schedule V | ||||||
12 | substance which
contains codeine, dihydrocodeine, or any | ||||||
13 | salts thereof, or
ethylmorphine, or any salts thereof, in | ||||||
14 | any 96 hour period. The
purchaser shall sign a form, | ||||||
15 | approved by the Department of Professional
Regulation, | ||||||
16 | attesting that he has not purchased any Schedule V
| ||||||
17 | controlled substances within the immediately preceding 96 | ||||||
18 | hours.
| ||||||
19 | (5) a copy of the records of sale, including all | ||||||
20 | information
required by paragraph (3), shall be forwarded | ||||||
21 | to the Department of
Professional Regulation at its | ||||||
22 | principal office by the 15th day of the following month.
| ||||||
23 | (6) all records of purchases and sales shall be | ||||||
24 | maintained for not
less than 2 years.
| ||||||
25 | (7) no person shall obtain or attempt to obtain within | ||||||
26 | any
consecutive 96 hour period any Schedule V substances of |
| |||||||
| |||||||
1 | more than 120
milliliters or more than 120 grams containing | ||||||
2 | codeine, dihydrocodeine or
any of its salts, or | ||||||
3 | ethylmorphine or any of its salts. Any person
obtaining any | ||||||
4 | such preparations or combination of preparations in excess
| ||||||
5 | of this limitation shall be in unlawful possession of such | ||||||
6 | controlled
substance.
| ||||||
7 | (8) a person qualified to dispense controlled | ||||||
8 | substances under this
Act and registered thereunder shall | ||||||
9 | at no time maintain or keep in stock
a quantity of Schedule | ||||||
10 | V controlled substances defined and listed in
Section 212 | ||||||
11 | (b) (1), (2) or (3) in excess of 4.5 liters for each
| ||||||
12 | substance; a pharmacy shall at no time maintain or keep in | ||||||
13 | stock a
quantity of Schedule V controlled substances as | ||||||
14 | defined in excess of 4.5
liters for each substance, plus | ||||||
15 | the additional quantity of controlled
substances necessary | ||||||
16 | to fill the largest number of prescription orders
filled by | ||||||
17 | that pharmacy for such controlled substances in any one | ||||||
18 | week
in the previous year. These limitations shall not | ||||||
19 | apply to Schedule V
controlled substances which Federal law | ||||||
20 | prohibits from being dispensed
without a prescription.
| ||||||
21 | (9) no person shall distribute or dispense butyl | ||||||
22 | nitrite for
inhalation or other introduction into the human | ||||||
23 | body for euphoric or
physical effect.
| ||||||
24 | (d) Every practitioner shall keep a record of controlled | ||||||
25 | substances
received by him and a record of all such controlled | ||||||
26 | substances
administered, dispensed or professionally used by |
| |||||||
| |||||||
1 | him otherwise than by
prescription. It shall, however, be | ||||||
2 | sufficient compliance with this
paragraph if any practitioner | ||||||
3 | utilizing controlled substances listed in
Schedules III, IV and | ||||||
4 | V shall keep a record of all those substances
dispensed and | ||||||
5 | distributed by him other than those controlled substances
which | ||||||
6 | are administered by the direct application of a controlled
| ||||||
7 | substance, whether by injection, inhalation, ingestion, or any | ||||||
8 | other
means to the body of a patient or research subject. A | ||||||
9 | practitioner who
dispenses, other than by administering, a | ||||||
10 | controlled substance in
Schedule II, which is a narcotic drug | ||||||
11 | listed in Section 206 of this Act,
or which contains any | ||||||
12 | quantity of amphetamine or methamphetamine, their
salts, | ||||||
13 | optical isomers or salts of optical isomers, pentazocine, or
| ||||||
14 | methaqualone shall do so only upon
the issuance of a written | ||||||
15 | prescription blank by a
prescriber.
| ||||||
16 | (e) Whenever a manufacturer distributes a controlled | ||||||
17 | substance in a
package prepared by him, and whenever a | ||||||
18 | wholesale distributor
distributes a controlled substance in a | ||||||
19 | package prepared by him or the
manufacturer, he shall securely | ||||||
20 | affix to each package in which that
substance is contained a | ||||||
21 | label showing in legible English the name and
address of the | ||||||
22 | manufacturer, the distributor and the quantity, kind and
form | ||||||
23 | of controlled substance contained therein. No person except a
| ||||||
24 | pharmacist and only for the purposes of filling a prescription | ||||||
25 | under
this Act, shall alter, deface or remove any label so | ||||||
26 | affixed.
|
| |||||||
| |||||||
1 | (f) Whenever a practitioner dispenses any controlled | ||||||
2 | substance except a non-prescription targeted methamphetamine | ||||||
3 | precursor regulated by the Methamphetamine Precursor Control | ||||||
4 | Act, he
shall affix to the container in which such substance is | ||||||
5 | sold or
dispensed, a label indicating the date of initial | ||||||
6 | filling, the practitioner's
name and address, the name
of the | ||||||
7 | patient, the name of the prescriber,
the directions
for use and | ||||||
8 | cautionary statements, if any, contained in any prescription
or | ||||||
9 | required by law, the proprietary name or names or the | ||||||
10 | established name
of the controlled substance, and the dosage | ||||||
11 | and quantity, except as otherwise
authorized by regulation by | ||||||
12 | the Department of Professional Regulation. No
person shall | ||||||
13 | alter, deface or remove any label so affixed.
| ||||||
14 | (g) A person to whom or for whose use any controlled | ||||||
15 | substance has
been prescribed or dispensed by a practitioner, | ||||||
16 | or other persons
authorized under this Act, and the owner of | ||||||
17 | any animal for which such
substance has been prescribed or | ||||||
18 | dispensed by a veterinarian, may
lawfully possess such | ||||||
19 | substance only in the container in which it was
delivered to | ||||||
20 | him by the person dispensing such substance.
| ||||||
21 | (h) The responsibility for the proper prescribing or | ||||||
22 | dispensing of
controlled substances is upon the prescriber and | ||||||
23 | the responsibility for
the proper filling of a prescription for | ||||||
24 | controlled substance drugs
rests with the pharmacist. An order | ||||||
25 | purporting to be a prescription
issued to any individual, which | ||||||
26 | is not in the regular course of
professional treatment nor part |
| |||||||
| |||||||
1 | of an authorized methadone maintenance
program, nor in | ||||||
2 | legitimate and authorized research instituted by any
| ||||||
3 | accredited hospital, educational institution, charitable | ||||||
4 | foundation, or
federal, state or local governmental agency, and | ||||||
5 | which is intended to
provide that individual with controlled | ||||||
6 | substances sufficient to
maintain that individual's or any | ||||||
7 | other individual's physical or
psychological addiction, | ||||||
8 | habitual or customary use, dependence, or
diversion of that | ||||||
9 | controlled substance is not a prescription within the
meaning | ||||||
10 | and intent of this Act; and the person issuing it, shall be
| ||||||
11 | subject to the penalties provided for violations of the law | ||||||
12 | relating to
controlled substances.
| ||||||
13 | (i) A prescriber shall not preprint or cause to be
| ||||||
14 | preprinted a
prescription for any controlled substance; nor | ||||||
15 | shall any practitioner
issue, fill or cause to be issued or | ||||||
16 | filled, a preprinted prescription
for any controlled | ||||||
17 | substance.
| ||||||
18 | (j) No person shall manufacture, dispense, deliver, | ||||||
19 | possess with
intent to deliver, prescribe, or administer or | ||||||
20 | cause to be administered
under his direction any anabolic | ||||||
21 | steroid, for any use in humans other than
the treatment of | ||||||
22 | disease in accordance with the order of a physician licensed
to | ||||||
23 | practice medicine in all its branches for a
valid medical | ||||||
24 | purpose in the course of professional practice. The use of
| ||||||
25 | anabolic steroids for the purpose of hormonal manipulation that | ||||||
26 | is intended
to increase muscle mass, strength or weight without |
| |||||||
| |||||||
1 | a medical necessity to
do so, or for the intended purpose of | ||||||
2 | improving physical appearance or
performance in any form of | ||||||
3 | exercise, sport, or game, is not a valid medical
purpose or in | ||||||
4 | the course of professional practice.
| ||||||
5 | (Source: P.A. 94-694, eff. 1-15-06; 94-830, eff. 6-5-06.)
|